These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 18419543)
21. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. Bezemer D; de Wolf F; Boerlijst MC; van Sighem A; Hollingsworth TD; Prins M; Geskus RB; Gras L; Coutinho RA; Fraser C AIDS; 2008 May; 22(9):1071-7. PubMed ID: 18520351 [TBL] [Abstract][Full Text] [Related]
22. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy. Haeri S; Shauer M; Dale M; Leslie J; Baker AM; Saddlemire S; Boggess K Am J Obstet Gynecol; 2009 Sep; 201(3):315.e1-5. PubMed ID: 19733286 [TBL] [Abstract][Full Text] [Related]
23. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy. Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217 [TBL] [Abstract][Full Text] [Related]
24. Management of HIV positive pregnancies in Ontario: current status. Gahir S; Anger GJ; Ibrahim M; Read S; Piquette-Miller M Can J Clin Pharmacol; 2009; 16(1):e68-77. PubMed ID: 19151422 [TBL] [Abstract][Full Text] [Related]
25. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study. Cozzi-Lepri A; Phillips AN; Clotet B; Mocroft A; Ruiz L; Kirk O; Lazzarin A; Wiercinska-Drapalo A; Karlsson A; Lundgren JD; AIDS; 2008 Oct; 22(16):2187-98. PubMed ID: 18832882 [TBL] [Abstract][Full Text] [Related]
26. Prevention of human immunodeficiency virus mother-to-child transmission in Israel. Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889 [TBL] [Abstract][Full Text] [Related]
27. Renal disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation. Szczech LA Curr Opin HIV AIDS; 2009 May; 4(3):167-70. PubMed ID: 19532045 [TBL] [Abstract][Full Text] [Related]
28. Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy. Gingelmaier A; Grubert TA; Kost BP; Setzer B; Lebrecht D; Mylonas I; Mueller-Hoecker J; Jeschke U; Hiedl S; Friese K; Walker UA Antivir Ther; 2009; 14(3):331-8. PubMed ID: 19474467 [TBL] [Abstract][Full Text] [Related]
29. Zidovudine monotherapy in pregnancy: is it state of the art? Taylor GP; O'Shea S; Mercey D; de Ruiter A HIV Med; 2009 Feb; 10(2):129-30; author reply 130-1. PubMed ID: 19200176 [No Abstract] [Full Text] [Related]
30. Anti-HIV agents. A few reasons for starting therapy at CD4+ counts above 350 cells. TreatmentUpdate; 2009 Jan; 21(1):4-5. PubMed ID: 19248283 [No Abstract] [Full Text] [Related]
31. Zidovudine monotherapy in pregnancy: is it state of the art? Katzenstein TL; Gerstoft J HIV Med; 2008 Aug; 9(7):445-7. PubMed ID: 18840149 [No Abstract] [Full Text] [Related]
32. [German-Austrian recommendations for HIV treatment during pregnancy and for newborns exposed to HIV--Update 2008]. ; ; ; ; ; ; ; Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S40-54. PubMed ID: 19172555 [No Abstract] [Full Text] [Related]
34. Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance. Furco A; Gosrani B; Nicholas S; Williams A; Braithwaite W; Pozniak A; Taylor G; Asboe D; Lyall H; Shaw A; Kapembwa M AIDS; 2009 Jan; 23(3):434-5. PubMed ID: 19188762 [No Abstract] [Full Text] [Related]
35. [Cross-sectional study on rates and influential factors of standard medication for antiretroviral therapy in preventing mother-to-child transmission of HIV]. Wang YZ; Li Y; Jiang CQ; Zheng M; Zhang Y; Xiong YH; Yang YY; Luo KM Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Apr; 43(4):277-81. PubMed ID: 19534946 [TBL] [Abstract][Full Text] [Related]
36. HIV remains a deadly disease. Lundgren JD HIV Med; 2004 Jul; 5(4):251-2. PubMed ID: 15236612 [No Abstract] [Full Text] [Related]
37. British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. de Ruiter A; Mercey D; Anderson J; Chakraborty R; Clayden P; Foster G; Gilling-Smith C; Hawkins D; Low-Beer N; Lyall H; O'Shea S; Penn Z; Short J; Smith R; Sonecha S; Tookey P; Wood C; Taylor G HIV Med; 2008 Aug; 9(7):452-502. PubMed ID: 18840151 [No Abstract] [Full Text] [Related]
38. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation. Vogel M; Rockstroh JK Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046 [TBL] [Abstract][Full Text] [Related]
39. Impact of HAART therapy on co-infection of tuberculosis and HIV cases for 9 years in Taiwan. Tseng SH; Jiang DD; Hoi HS; Yang SL; Hwang KP Am J Trop Med Hyg; 2009 Apr; 80(4):675-7. PubMed ID: 19346398 [TBL] [Abstract][Full Text] [Related]
40. Side effects and complications. HAART and the safety of the fetus. TreatmentUpdate; 2009 Feb; 21(2):6-7. PubMed ID: 19391263 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]